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In	  this	  article,	  we	  ask	  what	   is	  the	  place	  of	   institutional	  entrepreneurship	   in	  an	  (regional)	  
innovation	   system.	   The	   main	   research	   questions	   addressed	   are	   (a)	   how	   does	   a	   new	  
science-­‐based	   concentration	   of	   innovation	   become	   institutionalized	   in	   an	   innovation	  
system,	  (b)	  who	  are	  the	  institutional	  entrepreneurs	  and	  what	  do	  they	  actually	  do	  in	  their	  
efforts	   to	   institutionalize	   new	   beliefs,	   practices	   and	   activities	   within	   a	   system,	   and	   (c)	  
what	   knowledge	   institutional	   entrepreneurs	   do	   need	   and	   what	   kind	   of	   power	   do	   they	  
exercise	  in	  the	  institutionalization	  process.	  We	  add	  new	  knowledge	  to	  studies	  focusing	  on	  
innovation	   systems	   by	   revealing	   how	   new	   elements	   are	   attached	   into	   it.	   We	   also	   add	  
power	   and	   knowledge	   to	   the	   study	   of	   institutional	   entrepreneurship	   and	   institutional	  
change.	  The	  empirical	  analysis	  identifies	  the	  main	  phases	  of	  institutionalization,	  key	  actors	  
in	  different	  phases	  and	  their	  strategies	  of	  influence.	  This	  paper	  is	  based	  on	  the	  analysis	  of	  
secondary	  data	  and	  28	  interviews	  with	  key	  actors.	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1 Introduction	  
Studies	   focusing	   on	   innovation	   systems	   highlight	   the	   need	   for	   better	   understanding	   of	  
institutional	   change	   (Lundvall	   et	   al,	   2002,	  page	  255).	  Additionally,	   it	   has	  been	  observed	   that	  
various	   actors	   often	   need	   to	   innovate	   against	   the	   logics	   of	   the	   innovation	   system	   that	   is	  
supposed	   to	   support	   them	   (Hung	   and	  Whittington,	   2011).	   Consequently,	   we	   focus	   on	  what	  
actors	   actually	   do	  when	   they	   aim	   to	   boost	   the	   institutionalization	   of	   new	   concentrations	   of	  
science-­‐based	  innovation	  instead	  of	  studying	  the	  presence	  and/or	  absence	  of	  actors,	  as	  often	  
is	   the	   case	   (Uyarra,	   2010;	   Uyarra	   and	   Flanagan,	   2010,	   page	   683).	   We	   use	   the	   concept	   of	  
institutional	  entrepreneurship	  the	  aim	  being	  to	  complement	  the	  relatively	  established	  focus	  of	  
(regional)	   innovation	   system	   studies	   that	   primarily	   address	   organizations	   (actors	   as	  
components	   of	   systems),	   rules	   of	   the	   game	   (institutions),	   interaction	   patterns	   (networks),	  
innovation	  activities,	  knowledge	  flows	  and	  recently	  also	  knowledge	  bases	  (see	  e.g.	  Asheim	  and	  
Gertler,	  2005;	  Asheim	  and	  Isaksen,	  2002;	  Asheim	  et	  al,	  2006;	  Braczyk,	  Cooke	  and	  Heidenreich,	  
1998;	  Cooke,	  Uranga	  and	  Etxebarria,	  1997;	  Sternberg	  et	  al	  2010;	  Papaioannu	  et	  al	  2009).	  
The	  concept	  of	  institutional	  entrepreneurship	  adds	  to	  our	  knowledge	  of	  how	  social	  actors	  
work	  to	  change	  the	  institutions	  that	  govern	  innovation	  systems	  but	  also	  their	  own	  activity.	   It	  
improves	   our	   understanding	   of	   the	   ways	   in	   which	   power	   is	   exercised	   in	   institutionalization	  
processes,	   and	   how	   actors	   strategize	   and	   mobilize	   tangible	   and	   intangible	   resources	   for	  
institutional	   change	   (Garud,	   Hardy	   and	   Maguire,	   2007).	   As	   observed	   by	   Washington	   and	  
Ventresca	   (2004),	   the	   institutional	   entrepreneurship	   literature	  has	  not	  only	  made	  a	   valuable	  
empirical	   and	   theoretical	   contribution	   to	   our	   understanding	   of	   agency	   but	   also	   of	  
institutionalization	  as	  an	  on-­‐going	  multi-­‐actor	  process.	  Institutionalization	  is	  here	  defined	  as	  a	  
process	   of	   a	   new	   practice,	   activity,	   norm,	   belief,	   or	   some	   other	   institution,	   becoming	   an	  
established	   part	   of	   an	   existing	   system,	   organization	   or	   culture.	   As	   Scott	   (2001)	   maintains,	  
institutionalized	   practice	   has	   attained	   a	   high	   degree	   of	   resilience,	   and	   has	   become	  almost	   a	  
rule	   in	   collective	   thought	   and	   social	   action	   (Mignerat	   and	   Rivard,	   2012,	   page	   128).	  
Furthermore,	  d’Ovidio	  and	  Pradel	   (2012)	  add	  that	   the	   formation	  of	  collectives	  of	  actors	  who	  
defend	   the	   emergence	   of	   a	   new	   institution	   are	   an	   essential	   part	   of	   the	   institutionalization	  
process.	  	  
We	  investigate	  institutional	  entrepreneurship	  and	  the	  institutionalization	  process	  by	  using	  
the	  emergence	  of	  regenerative	  medicine	  in	  Tampere,	  Finland,	  as	  a	  case	  in	  point.	  It	  constitutes	  
an	  interesting	  case	  for	  analysis	  for	  two	  reasons.	  First,	  regenerative	  medicine	  is	  a	  novel	  branch	  
of	   medicine	   as	   well	   as,	   potentially,	   a	   medical	   business	   with	   highly	   interdisciplinary	  
characteristics.	   Second,	  despite	   its	   relatively	   short	  history,	   the	  concentration	  of	   regenerative	  
medicine	   in	   Tampere	   is	   locally,	   nationally	   and	   internationally	   recognized	   as	   a	   source	   of	  
innovation.	   It	   is	   a	   case	  of	  how	  a	  new	  element	   can	  become	   institutionalized	   in	   a	   knowledge-­‐
producing	  sub-­‐system	  of	  an	   innovation	  system	  (on	  sub-­‐systems	  of	  an	   innovation	  system,	  see	  
Autio,	  1998).	  
The	   main	   of	   the	   paper	   is	   to	   identify	   the	   place	   of	   institutional	   entrepreneurship	   in	  
innovation	   systems.	   The	   three	   interrelated	   research	  questions	  we	   set	   out	   to	   address	   are	   (a)	  
how	   does	   a	   new	   science-­‐based	   concentration	   of	   innovation	   become	   institutionalized	   in	   an	  
innovation	  system,	  (b)	  who	  are	  the	  institutional	  entrepreneurs	  and	  what	  do	  they	  actually	  do	  in	  
their	   efforts	   to	   institutionalize	   new	   beliefs,	   practices	   and	   activities	   within	   a	   system,	   and	   (c)	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what	  knowledge	  institutional	  entrepreneurs	  do	  need	  and	  what	  kind	  of	  power	  do	  they	  exercise	  
in	   the	   institutionalization	   process.	  We	   aim	   to	   add	   to	   the	   few	   studies	   that	   have	   focused	   on	  
institutional	   entrepreneurship	   in	   the	   context	   of	   innovation	   systems	   (e.g.	   Drori	   and	   Landay	  
2011;	  Hung	  and	  Whittington	  2011;	  Ritvala	  and	  Kleymann	  2012;	  Sotarauta	  and	  Pulkkinen	  2011).	  
We	  contribute	  to	  the	  institutional	  entrepreneurship	  literature	  by	  exploring	  the	  important	  but	  
understudied	   link	   between	   institutional	   entrepreneurship	   and	   innovation	   systems,	   focusing	  
specifically	  on	  institutional	  agency,	  power	  and	  knowledge.	  
2 Conceptual	  framework	  
2.1 Institutional	  entrepreneurship	  	  
By	  employing	  the	  concept	  of	   institutional	  entrepreneurship	   it	   is	  possible	  to	  tackle	  a	  common	  
pitfall	  of	   regional	   innovation	   studies,	  namely	   ‘the	  constant	   temptation	   to	  want	   to	   “read	  off”	  
individual	   behaviour	   from	  national	   (or	   local)	   institutional	   structures’	   (Gertler,	   2010,	   page	   5).	  
Institutional	   entrepreneurship	   literature	   is	   based	   on	   DiMaggio’s	   (1988)	   observation	   that	  
organized	  actors	  not	  only	   comply	  with	   institutions	  but	   consciously	   aim	   to	   create	   them	  or	   to	  
transform	   existing	   institutions.	   As	   DiMaggio	   (1988,	   page	   14)	   argues:	   ‘new	   institutions	   arise	  
when	  organized	  actors	  with	  sufficient	  resources	  see	  in	  them	  an	  opportunity	  to	  realize	  interests	  
that	  they	  value	  highly’.	  Battilana,	  Leca	  and	  Boxenbaum	  (2009)	  remind	  us	  that	  these	  actors	  can	  
be	  organizations	  or	  groups	  of	  organizations	  or	  individuals	  or	  groups	  of	  individuals.	  Institutional	  
entrepreneurs	   are	   actors	   who	   initiate	   divergent	   changes	   and	   actively	   participate	   in	   the	  
implementation	  of	  them.	  These	  efforts	  reflect	  the	  many	  strategies	  adopted	  by	  relevant	  groups	  
of	   actors	   aiming	   to	   break	   away	   from	   the	   path	   previously	   followed	   and	   create	   new	   ones.	  
Pacheco	   et	   al	   (2010,	   page	   978)	  maintain	   that	   the	   sociologically	   oriented	   institutional	   theory	  
focuses	  on	  ‘the	  organizational	  field	  and	  the	  ways	  actors	  engage	  in	  entrepreneurship	  in	  a	  quest	  
for	  legitimacy’.	   Institutional	  entrepreneurs	  need	  to	  be	  able	  to	  (a)	  challenge	  existing	  rules	  and	  
practices	  and	  (b)	  institutionalize	  the	  alternative	  rules	  and	  practices	  they	  are	  striving	  for	  (Garud	  
and	  Karnøe,	  2003).	  	  
Institutional	   theory	   treats	   institutions	  as	   socially	  constructed	   rule	  systems,	  norms	  and/or	  
institutionalized	  practices	  and	  belief	  systems	  that	  produce	  routine-­‐like	  behaviour	  (Pacheco	  et	  
al,	  2010,	  page	  980).	  As	  such,	   institutions	  are	  an	  interesting	  target	  of	   investigation	  as	  they,	  by	  
definition,	   imply	   permanence	   and	   stability.	   Institutions	   are	   resistant	   to	   change	   by	   nature.	  	  
There	  are	  often	  sanctions	  for	  actions	  deviating	  from	  what	  is	  framed	  as	  right	  by	  institutions	  in	  
one	  way	  or	  another.	  Battilana	  et	  al	  (2009,	  page	  67)	  pose	  the	  question	  central	  to	  all	  the	  studies	  
focusing	   on	   institutional	   entrepreneurship:	   ‘if	   our	   norms	   and	   collective	   beliefs	   are	  
institutionally	   determined,	   how	   can	   human	   agency	   be	   a	   factor	   in	   institutional	   change?’	   The	  
freedom	  of	   institutional	   entrepreneurs	   to	   forge	   change	   is	   not	  only	   limited	  by	   the	   very	   same	  
institutions	   they	   aim	   to	   change	   (Battilana,	   2006;	   Leca	   and	   Naccache,	   2006;	   Seo	   and	   Creed,	  
2002)	   but	  when	   grasping	   the	   opportunity	   to	   change	   institutions,	   institutional	   entrepreneurs	  
also	  take	  considerable	  risks.	  
According	  to	  Battilana	  et	  al	  (2009,	  page	  67)	  studies	  on	  institutional	  entrepreneurship	  have	  
consequently	  been	  criticized	  for	  ignoring	  institutional	  pressures	  and	  thus	  portraying	  actors	  as	  
some	  kind	  of	  disembedded	  agents	  –	  heroes	  of	   institutional	  change	  (Meyer,	  2006,	  page	  732).	  
The	  few	  existing	  studies	  on	   institutional	  entrepreneurship	   in	   innovation	  systems	  convincingly	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challenge	  the	  rationalistic	  and	  heroism-­‐inclined	  line	  of	  research	  by	  revealing	  the	  collective	  and	  
processual	   nature	   of	   institutional	   entrepreneurship	   (Drori	   and	   Landau,	   2011;	   Hung	   and	  
Whittington,	  2011;	  Ritvala	  and	  Kleymann,	  2012;	  see	  also	  Forbes	  2012).	  A	  study	  on	  functional	  
foods	   shows	   that	   institutional	   entrepreneurship	   is	   often	   an	   unplanned,	   highly	   personal	   and	  
intuitive	   form	  of	   agency	   (Ritvala	   and	   Kleymann,	   2012)	   and,	   in	   his	   study	   on	   nanotechnology,	  
Kulve	   (2010)	   reveals	   the	   patchwork	   nature	   of	   institutional	   change	   and	   the	   ways	   in	   which	  
institutional	  entrepreneurs	  ‘softly’	  frame	  the	  conditions	  for	  future	  development.	  Interestingly,	  
he	  also	  points	  out	  the	  significance	  of	  timing	  by	  analysing	  the	  ‘waiting	  games’	  needed	  to	  reduce	  
the	  uncertainties	  around	  new	   technologies.	  Drawing	  on	   their	   action	   research	  of	   institutional	  
changes	   in	   academic	   research	   in	   the	   Basque	   Country,	   Karlsen	   et	   al	   (2012)	   conclude	   that	  
institutional	  entrepreneurs	  proved	  to	  be	  important	  in	  the	  long	  run	  as	  they	  bridged	  macro	  level	  
(policy)	   and	  micro	   level	   (academic	   research)	   in	   a	   process	   of	   cogeneration.	   In	   their	   study	   on	  
institutional	  change	  concerning	  science	  in	  Israel,	  Drori	  and	  Landau	  (2011)	  stress	  the	  power	  of	  
vision	   in	   institutional	   change	   and	   especially	   the	  way	   existing	   visions	   produce	   continuity	   but	  
interact	  with	  new	  visions	  that	  push	  for	  institutional	  change.	  	  
2.2 Power	  
The	   observations	   from	   the	   earlier	   studies,	   referred	   to	   briefly	   in	   the	   previous	   section,	   locate	  
institutional	   entrepreneurship	   not	   in	   the	   attributes	   of	   individuals	   but	   in	   the	   relationships	  
connecting	  actors	  in	  an	  institutionalization	  process.	  Institutional	  entrepreneurship	  is	  not	  about	  
specialized	   and	   specific	   roles	   but	   diffuse	   processes	   in	   which	   different	   actors	   have	   different	  
ways	  to	  influence	  the	  course	  of	  events.	  Therefore,	  it	  is	  important	  to	  understand	  what	  kind	  of	  
power	   the	   key	   actors	   exercise	   and	   how	   power	   relations	   evolve	   over	   time	  with	   institutional	  
change.	  
Power	   is	   ‘the	   capacity	   of	   some	   persons	   to	   produce	   intended	   and	   foreseen	   effects	   on	  
others’	  (Wrong,	  1997,	  page	  2).	  We	  also	  need	  to	  take	  into	  account	  the	  power	  of	  social	  systems	  
and	  structures,	   i.e.	   the	  fact	  that	   institutions	  are	  actually	  both	  subjects	  and	  objects	  of	  change	  
and/or	  stability.	  As	  Foucault	  (1980)	  claims,	  belief	  systems	  gain	  power	  when	  groups	  of	  people	  
accept	  a	  belief	  system	  and	  take	  it	  for	  granted.	  Belief	  systems	  define	  the	  arena	  for	  many	  actors,	  
affect	   institutional	   design,	   and	   are	   often	   institutions	   in	   themselves	   (Foucault,	   1980)	   and	  
therefore,	   we	   also	   need	   to	   acknowledge	   the	   relational	   effect	   of	   social	   interaction	   and	   see	  
power	   as	   the	   relational	   effect	   of	   social	   interaction	   (Allen,	   2003,	   page	  2,	   page	  60–64).	   In	   the	  
empirical	   analysis,	   we	   use	   the	   three	   forms	   of	   power	   identified	   by	   Sotarauta	   (2009):	  
interpretive	  power,	  network	  power	  and	  institutional	  power.	  
Interpretive	  power	  refers	  to	  power	  deriving	  from	  the	  skills	  and/or	  expertise	  of	  an	  actor	  to	  
create	   a	   new	   vocabulary	   and	   a	   new	  way	   of	   seeing	   innovation	   systems	   and	   core	   innovation	  
activities.	  The	  power	  to	  frame	  issues	  discussed,	  to	  lead	  sense-­‐making	  processes	  and	  hence	  to	  
influence	   what	   issues	   are	   on	   the	   agenda	   and	   what	   are	   not,	   and	   consequently	   also	   who	   is	  
involved	   in	   the	   interactive	   communication	   loop,	   are	  ways	   to	  mould	   social	   filters	   that	   render	  
some	  courses	  of	  action	  easier	  than	  others	  (Rodrìguez-­‐Pose,	  1999,	  page	  82;	  Rodríguez-­‐Pose	  and	  
Crescenzi	  2008,	  page	  52).	  Actors	  with	  network	  power	  have	  resources	  to	  convene	  other	  actors	  
for	  dialogue	  and	  remove	  obstacles	  of	  communication	  between	  various	  actors.	  They	  can	  utilize	  
the	   resources	   and	   competencies	   of	   their	   partners,	   set	   the	   agenda,	   resolve	   conflict,	   enable	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information	   flow,	   build	   trust,	   orient	   people	   to	   their	   places	   and	   roles,	   inspire	   and	   excite.	  
Interpretive	  and	  network	  power	  do	  not	  refer	  to	  efforts	  to	  seek	  consensus	  but	  efforts	  to	  create	  
common	   ground	   for	   shared	   thinking	   and	   joint	   efforts	   to	   transform	   the	   institutions	   for	   the	  
future	  (Sotarauta,	  2009).	  	  
Even	   though	   interpretive	   and	   network	   power	  were	   highlighted	   in	   the	   study	   on	   regional	  
development	  officers	   (Sotarauta,	  2009),	   the	   importance	  of	   institutional	  power	  should	  not	  be	  
neglected.	  This	  refers	  to	  the	  power	  to	  act	  and	  decide	  and	  the	  power	  to	  create	  institutions	  and	  
formulate	  official	   strategies,	   i.e.	  direct	  power	  exercised	  by	  official	  actors.	   Institutional	  power	  
involves	  also	  the	  power	  to	  direct	   resources.	   It	   is	  assumed	  here	  that	   the	   forms	  of	  power	  that	  
institutional	   entrepreneurs	   exercise	   stretch	   from	   collective	   and	   integrative	   action	   (enabling,	  
power	  to	  do)	  to	  instrumental	  abilities	  that	  provide	  actors	  with	  influence	  at	  the	  expense	  of	  the	  
others	  (power	  over)	  (Allen,	  2003,	  pages	  51–52).	  
2.3 Three	  facets	  of	  knowledge	  
To	   mobilize	   actors	   and	   competencies,	   institutional	   entrepreneurship	   requires,	   alongside	  
power,	   the	   capacity	   to	   integrate	   various	   forms	   of	   knowledge.	   In	   the	   innovation	   system	  
literature,	  two	  main	  approaches	  to	  knowledge	  predominate.	  First,	  knowledge	  is	  contemplated	  
using	   simplified	   distinctions	   as	   tacit/codified,	   implicit/	   explicit	   and	   local/global	   (see	   Tsoukas,	  
1996,	  Orlikowski,	  2002).	  Second,	  knowledge	  is	  often	  seen	  as	  a	  matter	  of	  content,	  signifying	  the	  
rationalistic	  strategy	  that	  treats	  knowledge	  as	  an	  independent	  factual	  object	  and	  which	  relates	  
it	  to	  an	  ‘exact’	  science	  (Allen,	  2003).	  If	  we	  consider	  institutional	  entrepreneurship	  as	  a	  diffused	  
process	   aimed	   at	   shaping	   the	   institutional	   set-­‐up	   for	   innovation,	   we	   need	   to	   consider	  
knowledge	  more	  broadly	  and	  also	  take	  into	  account	  social	  interactive	  processes	  relating	  to	  its	  
generation	  and	  exploitation.	  We	  follow	  Yakhlef’s	  (2010)	  approach	  which	  includes	  three	  facets	  
of	  knowledge:	  1)	  knowledge	  as	  content	  referring	  to	  what	  is	  known	  or	  the	  corpus	  of	  knowledge	  
that	   does	   not	   belong	   to	   any	   particular	   individual	   or	   context,	   2)	   knowledge	   as	   a	   set	   of	  
knowledge-­‐productive	  practices	  and	  processes,	  and	  3)	  knowledge	  as	  a	   relation	   to	  a	  knowing	  
subject,	  where	   the	   cognizing	  unit	   is	   individuals-­‐in-­‐interactions,	  which	  means	   individuals	  who	  
are	  co/interdependent	  on	  one	  another’s	  knowledge	  (Yakhlehf,	  2010,	  page	  45).	  	  
Consequently,	   the	  process	  of	  generating	  new	  knowledge	  for	   institutional	  change	   is	   to	  be	  
seen	  as	  a	  distinction	  between	  ‘belief	  formation’	  and	  ‘knowledge	  justification’	  (Longino,	  2002).	  
Belief	   formation	   is	   a	   process	   that	   is	   motivated	   by	   an	   individual’s	   or	   a	   group	   of	   individuals’	  
drive,	  interest	  and	  passion	  for	  knowledge.	  It	  is	  based	  on	  the	  cognitive	  abilities	  of	  individuals	  to	  
generate	   ideas.	   To	   achieve	   the	   status	   of	   what	   counts	   as	   knowledge,	   the	   process	   of	   belief	  
formation	  requires	  the	  process	  of	  knowledge	  justification.	  The	  justificatory	  process	  cannot	  be	  
seen	  from	  the	  individual’s	  point	  of	  view	  since	  it	  requires	  discursive	  interactions	  with	  others	  if	  a	  
belief	   is	   to	   become	   part	   of	   the	   community	   knowledge	   base.	   For	   their	   part,	   the	   justificatory	  
processes	   vary	   between	   different	   communities.	   What	   comes	   to	   count	   as	   knowledge	   for	   a	  
certain	  community	  is	  defined	  by	  the	  community’s	  standards	  of	  justification,	  which	  are	  socially	  
institutionalized	  in	  a	  given	  space	  and	  time	  (see	  also	  Yakhlef,	  2010).	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3 The	  case,	  data	  and	  methodology	  	  
3.1 Regenerative	  medicine	  in	  Tampere	  
The	   case	   in	   this	   paper	   deals	  with	   the	   emergence	   of	   regenerative	  medicine	   in	   Tampere.	   The	  
term	   ‘regenerative	   medicine’	   was	   coined	   in	   2000	   and	   is	   now	   widely	   used	   to	   describe	  
biomedical	   approaches	   to	   heal	   the	   body	   by	   the	   stimulation	   of	   endogenous	   cells	   to	   repair	  
damaged	  tissues,	  or	   the	   transplantation	  of	  cells	  or	  engineered	  tissues	   to	   replace	  diseased	  or	  
injured	  tissues	  (Riazi,	  Kwon	  and	  Stanford,	  2009;	  see	  also	  Lysaght,	  Jaklenec	  and	  Deweerd,	  2007;	  
Mason	  and	  Dunnill,	  2008b).	  The	  basic	  unit	   in	  regenerative	  medicine	   is	  a	  stem	  cell.	  Stem	  cells	  
are	  biological	   cells	   found	   in	  all	  multicellular	  organisms.	  The	  potential	  of	   stem	  cells	   in	   clinical	  
treatments	  is	  based	  on	  their	  multi-­‐potent	  ability.	  Stem	  cells	  are	  able	  to	  regenerate	  tissues	  and	  
organs	  and	  act	  as	  building	  blocks	  for	  all	  tissues	  in	  the	  body	  (Nordforsk,	  2007;	  NIH,	  2010;	  Regea,	  
2010).	  	  
Regenerative	   medicine	   has	   grown	   rapidly	   in	   the	   past	   decade	   and	   the	   scientific	  
achievements	   have	   created	   hopes	   of	   new	   treatments	   for	   severe	   incurable	   diseases,	   such	   as	  
diabetes,	   Parkinson’s	   disease,	   cancer	   and	   heart	   diseases.	   The	   promise	   of	   regenerative	  
medicine	   is	   very	   exciting	   but	   simultaneously	   the	   cost	   of	   product	   development,	   and	   most	  
notably	   clinical	   trials,	   for	   the	   high-­‐end	   applications	   is	   very	   high	   (Mason	   and	   Dunnill,	   2008a,	  
page	   351).	   Simultaneously,	   regenerative	   medicine	   faces	   constant	   complex	   ethical	   and	  
legislative	  questions.	  Much	  of	  the	  stem	  cell	  based	  research	  is	  covered	  by	  statutes	  concerning	  
clinical	  medical	  research	  in	  general	  and	  only	  a	  few	  countries	  have	  adopted	  legislation	  devoted	  
to	   stem	  cell	   research	  per	   se.	   The	   legislation	  on	   stem	  cell	   research,	   and	  especially	  on	  human	  
embryonic	   research,	   varies	   widely	   in	   Europe.	   In	   Finland,	   the	   ethical	   atmosphere	   and	   the	  
legislation	  have	  been	  mostly	  permissive	  (Nordforsk,	  2007).	  
The	   core	   of	   this	   case	   is	   the	   Regea	   Institute	   for	   Regenerative	   Medicine	   that	   is	   a	   joint	  
institute	   under	   the	   administration	   of	   the	  University	   of	   Tampere.	   Regea	  was	   founded	   by	   the	  
University	  of	  Tampere,	  the	  Tampere	  University	  of	  Technology,	  the	  Pirkanmaa	  Hospital	  District,	  
the	  Pirkanmaa	  University	  of	  Applied	  Sciences	  and	  Coxa,	  the	  Hospital	  for	  Joint	  Replacement	  in	  
2005.	  The	  focal	  research	  areas	  are	  stem	  cell	  research	  and	  research	  combining	  stem	  cells	  and	  
biomaterials.	  The	  focus	  is	  on	  R&D	  that	  enables	  the	  design	  of	  new	  forms	  of	  treatment	  based	  on	  
tissue	   engineering.	   Regea	   has	   numerous	   academic	   and	   firm	   partners	   locally,	   nationally	   and	  
internationally	   (biomaterial	   engineers,	   clinicians,	   cell	   biologists,	   technical	   experts,	   animal	  
model	   experts,	   and	   so	   on).	   One	   of	   the	   strategic	   partners	   is	   the	   Tampere	   University	   of	  
Technology.	   Its	   department	   of	   Biomedical	   Engineering	   represents	   the	   highest	   expertise	   in	  
biomaterials	  and	  tissue	  engineering,	  as	  well	  as	  biomeasuring,	  in	  Finland.	  	  
3.2 Data	  and	  methodology	  
The	  empirical	  study	  began	  with	  a	  literature	  review	  of	  the	  history	  of	  Regea,	  as	  well	  as	  stem	  cell	  
research	   based	   on	   written	   material	   from	   the	   Internet,	   relevant	   journals,	   dozens	   of	   related	  
newspaper	   articles,	   Regea’s	   annual	   reports,	   respective	   policy	   documents	   and	   minutes	   of	  
Regea’s	  founding	  planning	  groupage	  Drawing	  on	  the	  secondary	  data,	  the	  history	  of	  Regea	  and	  
related	   activities	   were	   constructed	   chronologically.	   The	   main	   aim	   of	   this	   exercise	   was	   to	  
describe	   the	   case	   and	   its	   evolution	   from	   the	   early	   days	   to	   the	   present	   day	   focusing	   on	   a	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sequence	  of	  events	  and	  critical	  incidents.	  This	  phase	  identified	  a	  generic	  development	  pattern	  
and	  critical	  incidents	  for	  further	  data	  gathering	  and	  analysis.	  	  
Next,	   28	   people,	   involved	   in	   different	   phases	   of	   the	   process	   under	   scrutiny,	   were	  
interviewed.	  Six	  of	  the	  interviewees	  were	  employees	  of	  Regea	  (the	  director,	  the	  team	  leaders	  
and	   the	   quality	   manager)	   and	   the	   rest	   of	   the	   interviewees	   were	   from	   local	   and	   regional	  
development	   agencies,	   Tampere	   University	   Hospital,	   the	   Universities,	   the	   Finnish	   Funding	  
Agency	   for	   Technology	   and	   Innovation	   and	   the	   Finnish	   Medicines	   Agency.	   The	   interviews	  
followed	  the	  idea	  of	  the	  narrative	  interview	  (see	  Czarniawska,	  2006)	  augmented	  with	  thematic	  
clarifications.	   The	   themes	  were:	   (1)	  Temporal	   change.	  When	   the	   interviewee	  participated	   in	  
the	  process,	  what	  happened	  and	  why?	  What	  were	  the	  critical	  incidents	  and	  significant	  events,	  
and	  why	  were	  they	  significant?	  What	  actually	  happened	  and	  when,	  and	  who	  did	  what	  in	  these	  
events?	   When	   did	   these	   events	   occur?	   (2)	   Institutions.	   What	   kinds	   of	   institution	   enabled	  
and/or	   hampered	   the	   development	   of	   regenerative	   medicine	   in	   Tampere?	   How	   were	  
institutional	   obstacles	   overcome?	   (3)	   The	   roles	   of	   the	   actors.	  Who	   influenced	   the	   course	   of	  
events,	  how	  and	  why?	  The	  main	  aim	  was	  to	  construct	  a	  narrative	  of	  the	  sequence	  of	  events	  to	  
identify	  the	  actions	  of	  key	  people	  in	  their	  efforts	  to	  influence	  the	  process	  and	  thus	  to	  find	  out	  
what	   drives	   process	   and	   how	   these	   kind	   of	   processes	   are	   intentionally	   directed	   to	   serve	  
several	  fields	  of	  interest.	  	  
4 Sequence	  of	  events	  and	  the	  institutional	  entrepreneurs	  carrying	  them	  forward	  
4.1 How	  does	  one	  grow	  an	  upper	  jaw	  within	  a	  stomach	  muscle?	  	  
The	  point	  of	  departure	  here	  is	  the	  fact	  that	  in	  2008,	  for	  the	  first	  time	  in	  the	  world,	  a	  patient’s	  
upper	  jaw	  was	  replaced	  with	  a	  bone	  transplant	  cultivated	  from	  the	  stem	  cells	  isolated	  from	  the	  
patient’s	  own	  fatty	  tissue,	  as	  illustrated	  in	  Figure	  1.	  The	  patient	  had	  lost	  roughly	  half	  his	  upper	  
jaw	   because	   of	   cancer	   and	   traditional	   medicine	   was	   unable	   to	   offer	   remedial	   treatment.	  
Today,	  after	  the	  surgery,	  based	  on	  the	  technology	  created	  by	  Regea	  with	  its	  collaborators	  and	  
carried	  out	  by	  the	  Helsinki	  University	  Hospital,	   the	  patient	   is	  able	  to	   live	  a	  normal	   life	  with	  a	  
normal	   upper	   jaw.	   In	   the	   process,	   the	   scientists	   were	   able	   to	   produce	   new	   bone	   cells	   by	  
combining	  stem	  cells	  and	  biomaterials	  and	  then	  growing	  them	  into	  a	   jawbone	  of	   the	  correct	  
shape	  and	  size	  (with	  the	  aid	  of	  a	  titanium	  frame)	  inside	  the	  patient’s	  stomach	  muscle.	  Over	  a	  
period	  of	   six	  months,	   the	   contents	  ossified	  and	  were	   filled	  with	  blood	  vessels.	   The	  designed	  
bone	  and	   the	   surrounding	  muscle	  were	   then	   removed,	   together	  with	   the	  blood	  vessels,	   and	  
fitted	  in	  place	  (Suomen	  Kuvalehti,	  2008;	  Bionext,	  2010).	  This	  operation	  was	  a	  continuation	  of	  
successful	  clinical	  treatments	  undertaken	  in	  2007,	  in	  which	  two	  patients	  with	  bone	  deficiencies	  
were	   treated,	   jointly	   with	   the	   Tampere	   University	   Hospital,	   with	   a	   combination	   of	   fat	   stem	  
cells	   and	   biomaterials.	   By	   the	   end	   of	   2010,	   based	   on	   this	   technology,	   approximately	   30	  
patients	  with	  serious	  bone	  deficiencies	  had	  been	  treated	  in	  Finnish	  hospitals	  (Bionext,	  2010).	  
In	  comparison,	  by	  early	  2010,	  analogous	  treatment	  (external	  to	  the	  Regea	  network)	  has	  been	  
received	  by	  only	  one	  patient	  in	  Germany	  (Tekes,	  2010).	  	  
The	  breakthrough	  upper	  jaw	  operation	  and	  the	  successful	  clinical	  treatments	  were	  critical	  
incidents	   that	   were	   part	   of	   the	   institutionalization	   process	   of	   regenerative	   medicine.	   The	  
whole	   process	   can	   be	   divided	   into	   four	   main	   phases:	   (a)	   sowing	   the	   seeds	   of	   change;	   (b)	  
collective	  belief	  formation;	  (c)	  launch	  of	  activity;	  (d)	  institutionalization.	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Figure	  1.	  Illustration	  of	  the	  missing	  part	  of	  the	  upper	  jaw	  and	  the	  location	  of	  the	  upper	  jaw	  
inside	  the	  stomach	  muscle	  (authors’	  own	  drawing	  based	  on	  Suomen	  Kuvalehti	  2008)	  
4.2 Sowing	  the	  seeds	  of	  change	  
The	   sowing	   of	   the	   seeds	   of	   change	   dates	   back	   to	   1986	   when	   Professor	   Pertti	   Törmälä	   and	  
Pentti	   Rokkanen,	   a	   surgeon,	   produced	   a	   bioabsorbable	   screw	   for	   repairing	   bone	   fractures	   –	  
the	   first	   in	   the	   world.	   In	   order	   to	   launch	   new	   products	   in	   the	   European	   and	   US	   markets,	  
Törmälä	   and	   his	   group	   established	   the	   first	   two	   enterprises.	   Since	   then,	   the	   industry	   has	  
evolved	   and	   today	   Tampere	   is	   acknowledged	   as	   one	   of	   the	   key	   centres	   of	   biomaterials	   in	  
Finland	   (Restructuring	   and	   Development	   of	   Biosciences	   in	   Finland,	   2007).	   In	   the	   1990s,	   the	  
focus	  of	   global	   biomaterial	   research	   started	   to	   change.	   It	   began	   to	   shift	   from	  bioabsorbable	  
implants	  towards	  stem	  cell	  biology.	  At	  the	  same	  time,	  regenerative	  medicine	  had	  just	  started	  
to	  progress	  rapidly,	  with	  tremendous	  hype	  as	  well	  as	  hope.	  The	  most	  positive	  commentators	  
argued	   that	   regenerative	  medicine	   would	   become	   one	   of	   the	   three	  main	   forms	   of	   medical	  
treatment	   alongside	  medication	   and	   surgery	   (Valtakari,	   Rajahonka	   and	   Tikkanen,	   2007).	   The	  
most	  negative	  commentators,	  for	  their	  part,	  argued	  that	  regenerative	  medicine	  is	  full	  of	  empty	  
promises	  and	  more	  hype	  than	  actual	  treatments	  (for	  more,	  see	  Brown,	  2003;	  Nadig,	  2009).	  In	  
Tampere,	  the	  key	  actors	  in	  the	  field	  of	  biomaterials	  started	  to	  realize	  the	  potential	  offered	  by	  
stem	  cell	  biology	  for	  research	  as	  well	  as	  for	  local	  biomaterial	  firms.	  Importantly,	   local	  science	  
capacity	   in	   relation	   to	   stem	   cells	   and	   regenerative	   medicine	   in	   Tampere	   was	   fairly	   well	  
established.	  Professor	  Timo	  Ylikomi	  and	  his	  group	  conducted	  research	  on	  adult	  fat	  stem	  cells	  
at	   the	   University	   of	   Tampere	   and	   several	   research	   groups	   at	   the	   Tampere	   University	   of	  
Technology	  and	  the	  Technical	  Research	  Centre	  of	  Finland	  (VTT)	  were	   involved	  in	  research	  on	  
biomeasuring	  (biological	  and	  physiological	  measurement	  of	  human	  beings).	  	  
Missing part
The location of the growing upper jaw 
1
2
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The	   first	  seeds	  of	  change	  were	  sown	   in	   this	  ground	  as,	   in	   the	   late	  1990s,	  Professor	  Timo	  
Ylikomi	  and	  Professor	  Pertti	  Törmälä	  took	  the	  lead	  in	  initiating	  a	  new	  development	  trajectory	  
that	  eventually	   led	  to	  the	  facial	  bone	  replacements	  introduced	  above.	  Both	  of	  them	  believed	  
that	  there	  was	  ‘something	  more’	  in	  their	  research,	  and	  more	  widely	  in	  their	  fields,	  something	  
that,	   if	   applied	   correctly,	  might	   lead	   to	  new	  business,	  other	   forms	  of	   societal	  benefits,	  or	   to	  
boosting	   the	   competitiveness	  of	   existing	  biomaterial	   firms	   locally.	   This	   ‘scientific	  hunch’	  was	  
based	   on	   their	   expertise	   and	   long	   experience	   in	   their	   own	   fields.	   The	   two	   professors	  
individually	   introduced	   the	   idea	   of	   having	   an	   organization	   for	   regenerative	   medicine	   in	  
Tampere.	   The	   idea	   was	   fresh	   at	   that	   time;	   the	   ‘human	   spare	   parts’	   industry	   (regenerative	  
medicine)	  had	   just	   truly	  begun	   to	  emerge.	  The	  professors	  were	  prevented	   from	  taking	   rapid	  
action	  by	  two	  institutional	  obstacles:	  (a)	  the	  academic	  orientation	  of	  the	  University	  of	  Tampere	  
which	  focused	  more	  on	  academic	  excellence	  than	  the	  proactive	  search	  for	  new	  innovations	  or	  
business	  ventures,	  and	   (b)	   the	  scarcity	  of	   funds	  and	  know-­‐how	   in	  supporting	   innovation	  and	  
commercialization	  in	  this	  field.	  	  
In	  retrospect,	  it	  is	  possible	  to	  see	  what	  the	  outcomes	  of	  the	  science	  in	  question	  has	  been	  
and	   the	   successful	   treatments	   provide	   us	   with	   a	   convincing	   story	   that	   there	   was	   indeed	  
something	  in	  the	  air.	  At	  that	  time,	  nobody	  was	  able	  exhaustively	  to	  explain	  what	  the	  possible	  
outcomes	  might	  be	  and	  hence	  the	  first	  steps	  were	  hard	  to	  take.	  This	  is	  hardly	  a	  novel	  situation	  
in	   the	   advent	   of	   a	   science-­‐based	   innovation.	   By	   definition,	   innovation	   challenges	   prevailing	  
mind-­‐sets	  and	  practices	  and	  is	  often	  born	  in	  a	  climate	  of	  ambiguity,	  uncertainty	  and	  a	  lack	  of	  
clear	  vision	  (Lester	  and	  Piore,	  2004);	  as	  in	  this	  case,	  the	  inventors	  lack	  the	  capacity	  to	  simplify	  
the	   story	   and	   convince	   the	   resource-­‐holders	   outside	   the	   scientific	   core	   about	   the	   future	  
potential	  of	  the	  innovation.	  	  
4.3 Collective	  belief	  formation	  
It	   is	   often	   difficult	   for	   policy-­‐makers,	   funding	   bodies,	   and	   possible	   beneficiaries	   to	   see	   the	  
actual	   innovation	   through	   the	   hazy	   cloud	   of	   scientific	   reasoning	   seasoned	   with	   general	  
business	  noise	  generated	  by	  hype	  and	  hope,	   speculations	  and	  often	   fairly	  hollow	   innovation	  
policy	   rhetoric,	  more	  embedded	   in	  wishful	   thinking	   than	   factual	   evidence.	   This	  was	   also	   the	  
case	   in	   the	  early	  phases	  of	   the	  process	  under	   scrutiny.	  On	   the	  one	  hand,	   formal	   institutions	  
(the	   funding	   system,	   universities)	   as	   well	   as	   cognitive-­‐cultural	   institutions	   were	   not	  
immediately	  supportive.	  On	  the	  other	  hand,	  there	  was	  a	  local	  economic	  development	  system	  
in	   place	   that	   proved	   crucial	   in	   keeping	   the	   process	   in	   motion.	   A	   local	   support	   community	  
external	  to	  the	  academic	  spheres	  started	  to	  emerge	  to	  support	  the	  search	  by	  two	  professors	  
for	  new	  solutions	  to	  exploit	  the	  opportunities	  ‘in	  the	  air’.	  
The	   support	   community	   appears	   here	   as	   a	   crucial	   enabling	   factor	   for	   the	   institutional	  
entrepreneurship	  process	  to	  proceed	  without	  breaking.	  We	  define	  a	  support	  community	  as	  a	  
group	   of	   actors	   having	   a	   feeling	   of	   fellowship	   with	   others	   as	   a	   result	   of	   sharing	   common	  
attitudes,	  interests	  and	  objectives	  in	  terms	  of	  willingness	  to	  assist	  the	  process	  with	  all	  possible	  
means	  at	   their	   disposal.	   In	   this	   case,	   the	   support	   community	   consisted	  of	   local	   and	   regional	  
economic	   development	   actors	   as	   well	   as	   interested	   experts	   from	   the	   universities	   and	   the	  
Tampere	  University	  Hospital.	  The	  realization	  of	  these	  kinds	  of	  ideas	  is	  at	  the	  core	  of	  their	  work	  
and	  many	  of	   them	  also	   shared	   the	   conviction	  of	   the	  professors	   that	   science	   is	   there	   for	   the	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improvement	  of	  society	  and	  it	  ought	  to	  be	  commercialized	  if	  possible.	  Simultaneously	  with	  the	  
intensifying	   local	   discussions,	   the	   tissue	   engineering	   industry	   (regenerative	   medicine)	  
witnessed	   an	   ever-­‐accelerating	   global	   growth	   (Lysaght	   and	   Reyes,	   2001).	   This,	   of	   course,	  
boosted	   enthusiasm	   and	   belief	   in	   local	   capacity	   and	   fairly	   quickly	   the	   support	   community	  
decided	  to	  aim	  for	  a	  global	  business;	  Törmälä’s	  experience	  that	  this	  can	  actually	  be	  done	  and	  
his	   status	   as	   a	   local	   role	  model	   in	   translating	   science	   into	   practice	  was	   a	   strong	   impetus	   in	  
undertaking	  the	  process.	  	  
The	   Centre	   of	   Expertise	   Programme	   for	  Health	   Care	   Technology	   proved	   to	   be	   especially	  
important	  in	  the	  support	  community	  and	  beneficial	  for	  the	  continuation	  of	  the	  process.	  First,	  
there	   were	   development	   officers	   working	   for	   the	   programme	   whose	   job	   it	   was	   to	   boost	  
university–society	   (including	   business)	   interaction	   in	   the	   fields	   relevant	   to	   this	   case;	   second,	  
they	  followed	  closely	  the	  latest	  developments	  in	  the	  field	  and	  were	  quick	  to	  realize	  that	  there	  
was	  indeed	  a	  lot	  of	  potential	  in	  the	  local	  human	  fat	  and	  biomaterial	  research.	  Consequently,	  in	  
collaboration	  with	  other	  local	  and	  regional	  development	  agencies,	  they	  were	  also	  able	  to	  take	  
the	   lead	   in	   making	   the	   issue	   more	   understandable	   for	   the	   wider	   policy	   audience,	   decision	  
makers	  and	  resource	  holders,	  i.e.	  for	  actors	  with	  institutional	  power	  but	  not	  in-­‐depth	  content	  
knowledge.	  	  
To	  boost	  the	  process,	  the	  support	  community	  assigned	  an	  official	  planning	  group	  that	  was	  
excited	  about	  the	  global	  prospects	  and	  composed	  a	  business	  plan	  for	  a	  new	  business	  venture	  
through	   funding	   from	   the	   Employment	   and	   Economic	   Development	   Centre	   (a	   state	  
development	   agency	   at	   the	   regional	   level).	   In	   early	   2002,	   there	  was	   a	   strong	  belief	   that	   the	  
new	  venture	  would	  obtain	   funding	   from	  venture	   capitalists.	  However,	   in	   the	   course	  of	  2002	  
the	  situation	  began	  to	  change	  and	  by	  the	  end	  of	  the	  year	  it	  was	  already	  clear	  that	  there	  was	  
more	  global	  hype	  and	  hope	  than	  real	  business	  opportunities.	  Even	  though	  the	  number	  of	  firms	  
active	   in	   the	   field	   globally	   did	   not	   decline	   dramatically,	   the	   financial	   community’s	   faith	   in	  
regenerative	   medicine	   began	   to	   diminish.	   Despite	   public	   sector	   investment	   in	   R&D,	   the	  
industry	  had	  not	   yet	   succeeded	   in	  producing	  a	   single	  profitable	  and	  commercially	   successful	  
product	  (Lysaght	  and	  Hazlehurst,	  2004).	  The	  technology	  was	  not	  sufficiently	  mature,	  the	  safety	  
of	   the	   clinical	   applications	   was	   not	   adequate	   and	   true	   business	   opportunities	   were	   on	   the	  
distant	  horizon.	  	  
Consequently,	  the	  local	  planning	  group	  in	  Tampere	  realized	  that	   it	  would	  not	  be	  possible	  
to	  accomplish	   the	  business	  plan	  –	   there	  was	  no	  global	  business.	   There	  was	  no	  business	  and	  
hence	   no	   venture	   capital;	   the	   entire	   field	   appeared	   risky	   and	   enthusiasm	   started	   to	   wane.	  
However,	  it	  did	  not	  wither	  away	  entirely.	  The	  local	  potential	  was	  seen	  as	  too	  promising	  not	  to	  
be	   developed	   further	   and	   therefore	   the	   discussion	   shifted,	   emphasizing	   both	   the	   basic	   and	  
applied	  research	  idea.	  If	  there	  was	  no	  business	  opportunity,	  then	  let	  the	  research	  capacity	  at	  
the	  university	  be	  strengthened	  by	  launching	  a	  major	  research	  project.	  Although	  the	  emphasis	  
shifted	  from	  business	  to	  research,	  the	  idea	  of	  implementing	  a	  business	  venture	  remained	  the	  
main	  focus.	  The	  target	  was	  only	  postponed	  to	  the	  future.	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4.4 The	  launch	  of	  research	  activity	  
The	   launch	  of	   research	  activity	   saw	  not	  only	  a	  new	  emphasis	  but	  also	  new	  actors	   taking	   the	  
lead	   and	   those	   who	   had	   been	   in	   the	   forefront	   in	   the	   previous	   phases	   gradually	   moved	   to	  
become	  backstage	  operators.	  Instead	  of	  establishing	  a	  business	  venture,	  the	  launch	  of	  activity	  
included	   three	   main	   actions:	   (a)	   the	   establishment	   of	   a	   tissue	   bank;i	   (b)	   the	   eventual	  
establishment	   of	   the	   Regea	   Institute	   for	   Regenerative	   Medicine;	   (c)	   the	   recruitment	   of	  
person(s)	  to	  lead	  Regea.	  	  
After	  a	  series	  of	  negotiations	  between	  all	   the	  main	  parties	   in	  2002,	  the	  Employment	  and	  
Economic	  Development	  Centre	  committed	  to	  take	  part	  in	  the	  funding	  of	  Regea’s	  establishment	  
and	  especially	  the	  funding	  of	  a	  Good	  Manufacturing	  Practices	  (GMP)	  level	  laboratory	  and	  clean	  
room	   facilities.	   Another	   important	   funding	   body	  was	   the	   Pirkanmaa	  Hospital	   District	   (which	  
owns	  and	   runs	  Tampere	  University	  Hospital).	  One	  of	   the	   reasons	  behind	   the	  decision	  of	   the	  
Pirkanmaa	  Hospital	  District	  to	  become	  involved	  in	  Regea’s	  establishment	  was	  that	  the	  quality	  
requirements	  for	  tissue	  bank	  operations	  changed	  dramatically	  at	  that	  time.	   In	  Finland,	  tissue	  
bank	   operations	   had	   typically	   been	   taken	   care	   of	   by	   the	   hospitals	   themselves.	   The	   new	  
National	  Tissue	  Act	  and	  the	  European	  Union’s	  Tissues	  and	  Cell	  Directive	  (2004/23/EC)	  set	  strict	  
quality	   requirements	   for	   tissue	   banks	   in	   terms	   of	   storing	   and	   handling	   human	   tissues.	   The	  
Pirkanmaa	  Hospital	  District	  had	  two	  options:	  they	  were	  either	  to	  reorganize	  and	  upscale	  their	  
own	  tissue	  bank	  internally	  or	  to	  outsource	  the	  operations	  to	  some	  other	  organization	  with	  the	  
required	   facilities.	  Regea,	  with	   its	  new	   facilities	  due	   to	  be	  established,	  was	  a	   good	  option	   in	  
terms	  of	  coping	  with	  the	  changing	  situation;	  changes	  in	  the	  regulatory	  institutions	  opened	  new	  
doors	  for	  Regea.	  	  
The	  collective	  belief	  that	  was	  constructed	  in	  phase	  two	  proved	  to	  be	  sufficiently	  enticing	  to	  
a	  broader	  range	  of	  stakeholders.	  Now	  there	  was	  a	  broader	  and	  shared	  belief	  of	  the	  prospects	  
and	  requirements	  of	  regenerative	  medicine	  –	  a	  concrete	  project	  to	  work	  with	  –	  and	  making	  a	  
tissue	  bank	  was	  a	  crucial	  step	  for	  future	  development.	  At	  this	  point,	  it	  was	  significantly	  easier	  
for	  the	  resource	  holders	  and	  decision	  makers	  to	  see	  what	  might	  lie	  ahead.	  Also	  the	  leadership	  
of	   the	  University	  of	  Tampere	  became	  engaged	  and	  consequently	  Regea	  was	  established	  as	  a	  
research	   project	   in	   2004	   under	   the	   Institute	   of	   Medical	   Technology	   at	   the	   University	   of	  
Tampere.	  	  
In	   2005,	   Regea	   became	   an	   independent	   joint	   institute	   under	   the	   administration	   of	   the	  
University	  of	  Tampere.	  Although	  Regea	  was	  an	  academic	   institute,	   its	   focus	  was	  distinctly	  on	  
clinical	   applications,	   not	   primarily	   on	   basic	   research;	   its	   motto	   is	   ‘from	   research	   to	   clinical	  
care’.	   Regea	   started	   to	   conduct	   stem	   cell	   research	   early	   in	   2005	   and	   succeeded	   in	  
implementing	   its	   first	   clinical	   treatment	   in	  2007	   (Regea,	  2010).	  At	   that	   stage,	   it	   seemed	  that	  
there	  were	  only	  enabling	  factors	  such	  as	  a	  strong	  knowledge	  base	  and	  research	  capacity	  in	  the	  
field,	   an	   endowed	   professorship	   to	   the	   University	   of	   Tampere	   conferred	   by	   the	   city	   of	  
Tampere,	   and	   successful	   recruitment.	   The	   most	   visible	   of	   the	   recruitments	   occurred	   when	  
Regea	   succeeded	   in	   recruiting	   a	  world-­‐leading	   Finnish	   scholar,	   Professor	  Outi	   Hovatta,	   from	  
the	  Karolinska	  Institutet	  in	  Sweden	  to	  Regea	  due	  to	  the	  professorship	  endowed	  by	  the	  City	  of	  
Tampere.	   Aspects	   to	   her	   credit	   in	   Regea’s	   early	   days	   were	   twofold:	   (1)	   Regea’s	   stem	   cell	  
research	  began	  quickly	  because	  of	  her	  know-­‐how	  and	  she	  also	  brought	  with	  her	  the	  first	  seven	  
embryonic	   lines	   from	   the	   Karolinska	   Institutet	   to	   Regea,	   which	   was	   one	   of	   the	   factors	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underpinning	  the	  expeditious	  start	  of	  stem	  cell	  research	  in	  Tampere;	  (2)	  Regea	  became,	  more	  
or	   less	   instantly,	   a	   credible	   player	   in	   the	   academic	   and	   funding	   spheres	   and	   it	   also	   gained	  
considerable	   media	   visibility	   in	   Finland.	   As	   stated	   above,	   the	   changing	   legislation	   and	  
consequent	  establishment	  of	  the	  tissue	  bank	  operations	  also	  had	  a	  remarkable	  role	  in	  enabling	  
the	   surfacing	  of	  Regea.	   In	   addition,	   the	  atmosphere	   in	   terms	  of	  new	   innovative	   ideas	   in	   the	  
field	  of	  biotechnology	  was	  favourable	  in	  Tampere.	  In	  2003,	  the	  City	  of	  Tampere	  launched	  the	  
BioneXt	   Tampere	   programme	   aimed	   at	   the	   further	   development	   of	   the	   city’s	   biotechnology	  
sector.ii	  	  
At	  the	  end	  of	  the	  third	  phase,	  Regea	  not	  only	  had	  scientific	  and	  clinical	  credentials	  but	  also	  
global	  media	  attention.	  The	  future	  looked	  nothing	  but	  glorious.	  In	  practice,	  the	  process	  was	  far	  
from	   the	   aspirational	   goal.	   Regenerative	  medicine	   in	   Tampere	  was	   still	  more	   a	   collection	   of	  
research	   projects	   than	   a	   concentration	   of	   established	   research	   and	   innovation.	   In	   2009,	   the	  
basic	  funding	  from	  the	  University	  of	  Tampere	  covered	  only	  approximately	  one-­‐fifth	  of	  the	  total	  
budget.	   The	   rest	   of	   the	   budget	  was	   generated	   primarily	   through	   project	   funding	   from	   such	  
funding	   bodies	   as	   the	   Finnish	   Funding	   Agency	   for	   Technology	   and	   Innovation	   (Tekes),	   the	  
Academy	   of	   Finland	   (research	   councils)	   and	   the	   Employment	   and	   Economic	   Development	  
Centre.iii	   In	  addition,	  grants	   from	  other	   funding	  bodies,	   foundations	  and	  associations	  formed	  
an	  important	  part	  of	  the	  funding.	  Consequently,	  only	  three	  of	  the	  total	  personnel	  (appr.	  50–60	  
persons	   incl.	   doctoral	   students),	   had	   permanent	   positions	   while	   the	   others	   were	   employed	  
through	   fixed-­‐term	   contracts	   because	   of	   the	   non-­‐permanent	   nature	   of	   the	   funding	   (Regea,	  
2009).	  	  
4.5 Institutionalization	  	  
In	   the	   fourth	  phase,	  renewed	  support	   from	  both	   inside	  and	  outside	  the	  research	  and	  clinical	  
community	   was	   required	   to	   institutionalize	   all	   that	   had	   been	   accomplished	   in	   the	   earlier	  
phases.	   Breakthrough	   operations	   opened	   up	   new	   ways	   to	   treat	   severe	   tissue	   damage	   and	  
made	  the	  prospects	  of	  custom-­‐made	  living	  spare	  parts	  for	  humans	  a	  step	  closer	  to	  reality.	   In	  
the	  fourth	  phase,	  one	  of	  the	  main	  issues	  was	  the	  commercialization	  of	  the	  technology	  created	  
with	   limited	  financial	   resources	  available	   in	  the	  country.	  There	  had	  been	  several	  attempts	  to	  
find	  a	  way	  to	  do	  so,	  but	  the	  board	  of	  Regea	  and	  related	  actors	  were	  unable	  to	  find	  a	  viable	  way	  
to	   accomplish	   this,	   specifically	   from	   Finland,	   without	   selling	   the	   patents	   abroad.	   Second,	  
among	   the	   strategically	   important	   issues	   was	   whether,	   how	   and	   when	   Tampere	   University	  
Hospital,	  or	  some	  other	  hospital,	  would	  change	  its	  routines	  to	  integrate	  regenerative	  medicine	  
into	  its	  standard	  repertoire.	  At	  this	  point	  in	  time,	  the	  treatments	  were	  hugely	  expensive	  but	  if	  
they	  did	  not	  become	  a	  standard	  part	  of	  the	  hospital	  operations,	  the	  cost	  would	  not	  decrease.	  
Additionally,	   if	   the	  number	  of	   treatments	  were	   to	   grow,	  Regea	  would	  need	   to	   go	   through	  a	  
series	   of	   expensive	   clinical	   trials	   necessitated	   by	   pharmaceutical	   legislation.	   So	   far,	   the	  
institutional	  obstacles	  had	  kept	  the	  number	  of	  treatments	  at	  a	  low	  level.	  	  
Additionally,	  regenerative	  medicine	  is	  a	  field	  of	  science	  that	  requires	  patient	  and	  long-­‐term	  
funding	  to	  revolutionize	  medical	  care	  and	  therefore	  the	  main	  issues	  also	  include	  the	  scarcity	  of	  
long-­‐term	  research	  funding	   in	  the	  system	  as	  a	  whole	  and	  within	  the	  universities	   involved.	  To	  
remove	   this	   and	   other	   institutional	   obstacles,	   in	   2010,	   the	   University	   of	   Tampere	   merged	  
Regea	  and	  the	  Institute	  of	  Medical	  Technology	  and	  thus	  established	  a	  new	  organization	  named	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the	   Institute	   of	   Biomedical	   Technology	   (IBT).	   The	   University	   of	   Tampere	   also	   started	   to	  
formalize	   collaboration	   with	   the	   Tampere	   University	   of	   Technology	   and	   in	   2011	   a	   joint	  
platform,	  BioMediTech,	  with	  more	  than	  200	  scientists	  was	  established	  for	  future	  collaboration.	  
The	  City	  of	  Tampere	  launched	  a	  vision	  that	  Tampere	  would	  become	  the	  centre	  of	  human	  spare	  
parts	  in	  Finland	  and	  the	  Finnish	  Innovation	  and	  technology	  development	  fund	  (Tekes)	  granted	  
BioMediTech	  €10	  million	  in	  funding	  and	  substantial	  sums	  from	  other	  funding	  sources	  were	  also	  
raised.	   Regenerative	   medicine	   research,	   side	   by	   side	   with	   other	   branches	   of	   biomaterial	  
research,	  became	  institutionalized	   in	  the	   local	  as	  well	  as	  national	  system;	  nonetheless,	   it	  has	  
not	  yet	  been	  institutionalized	  as	  a	  permanent	  element	  of	  hospital	  treatments	  and/or	  business.	  
It	  is	  clear	  that	  these	  are	  the	  directions	  the	  newly	  established	  organizations	  are	  aiming	  for	  side	  
by	  side	  with	  scientific	  research. 	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TABLE	  1.	  Chronology	  of	  key	  events,	  actions	  and	  actors.	  	  
Phase	  and	  year	   Key	  events	  and	  actions	  	   Key	  actors	  







Bioabsorbable	  screw	  and	  the	  establishment	  
of	  the	  first	  biomaterial	  firms	  
Emergence	  of	  regenerative	  medicine	  
globally	  
First	  informal	  discussions	  concerning	  an	  
organization	  for	  regenerative	  medicine	  in	  
Tampere	  
	  















Global	  growth	  in	  regenerative	  medicine	  	  
Creation	  of	  an	  official	  planning	  group	  
Business	  plan	  for	  a	  new	  venture	  
The	  decline	  in	  global	  expectations	  	  






Local	  planning	  group	  
	  
Local	  planning	  group	  and	  the	  
leadership	  of	  UTA	  











Funding	  for	  a	  GMP	  level	  laboratory	  and	  
clean	  room	  facilities	  
BioneXt	  Tampere	  Programme	  
New	  tissue	  act	  and	  tissue	  and	  cell	  directive	  
Establishment	  of	  Regea	  as	  a	  project	  
	  
Establishment	  of	  tissue	  bank	  and	  Regea	  as	  
an	  independent	  joint	  institute	  
First	  clinical	  treatments	  	  
	  
Leadership	  of	  UTA	  
	  
City	  of	  Tampere,	  Finn-­‐Medi	  Ltd	  
and	  the	  universities	  
Leadership	  of	  UTA	  and	  local	  
planning	  group	  
Director	  of	  Regea	  	  
	  







First	  breakthrough	  treatment	  
Merger	  of	  Regea	  and	  IMT	  →	  IBT	  
Establishment	  of	  BioMediTech	  
Tekes	  grants	  €10	  million	  funding	  for	  
BioMediTech	  
	  
Research	  and	  clinical	  community	  
Leadership	  of	  UTA	  
Leadership	  of	  UTA	  and	  TUT	  
 
4.6 Key	  actors	  and	  their	  spheres	  of	  influence	  in	  the	  main	  phases	  of	  
institutionalization	  
The	   first	   of	   the	   research	   questions	   in	   this	   study	   was:	   How	   does	   a	   new	   science-­‐based	  
concentration	  of	  innovation	  become	  institutionalized	  in	  an	  innovation	  system?	  The	  case	  study	  
clearly	   shows	   that	   a	   process	   of	   institutionalization	   is	   far	   from	   a	   linear	   process	   flowing	   from	  
identification	  of	  a	  need	  to	  planning	  and	  finally	   implementation.	  Rather,	   it	   involves	  a	  series	  of	  
interrelated	  decisions	  and	  actions	  crossing	  many	  policy	  boundaries	  as	  well	  as	  involving	  several	  
institutional	  entrepreneurs.	  This	  confirms	  the	  observation	  of	  Ritvala	  and	  Kleymann	  (2011)	  that	  
institutional	   entrepreneurship	   is	   a	   process	   and	   collective	   action.	   To	   institutionalize	   a	   new	  
science-­‐based	   concentration,	   institutional	   entrepreneurs	   exert	   influence	   not	   only	  within	   the	  
boundaries	   of	   the	   organizations	   and	   communities	   that	   authorize	   them,	   or	  within	   their	   ‘own	  
policy	  domains’,	  but	  also	  beyond	  them.	  This	  study	  shows	  how,	  long	  before	  the	  actual	  launch	  of	  
a	   new	  activity,	   there	   are	   phases	   during	  which	   the	  new	   ideas	   begin	   to	   emerge	  without	   clear	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shape	   or	   understanding	   of	  what	   their	  meanings	  might	   be.	   The	   initial	   emergence	   of	   ideas	   is	  
followed	   by	   belief	   formation,	   resulting	   in	   a	   collective,	   but	   generic,	   understanding	   of	   what	  
might	  be	  at	  stake.	  Only	  after	  these	  phases	  can	  the	  actual	  institutionalization	  take	  place.	  
Next,	   we	   aim	   to	   answer,	   phase	   by	   phase,	   two	   other	   research	   questions:	   Who	   are	   the	  
institutional	  entrepreneurs	  and	  what	  do	  they	  actually	  do	  in	  their	  efforts	  to	  institutionalize	  new	  
beliefs,	  practices	  and	  activities	  into	  a	  system?	  What	  knowledge	  do	  institutional	  entrepreneurs	  
need	  and	  what	  kind	  of	  power	  do	  they	  exercise	  in	  the	  institutionalization	  process?	  
In	   the	   phase	   of	   sowing	   the	   seeds	   of	   change,	   the	   two	   professors	   were	   the	   institutional	  
entrepreneurs	  as	  they	  launched	  the	  process.	  They	  did	  not	  know	  where	  it	  might	  lead,	  but	  they	  
knew	  that	  there	  was	   ‘something	   in	  the	  air’	  and	  something	  major	  ought	  to	  be	  done.	  They	  did	  
not	  have	  the	  institutional	  power	  required	  to	  take	  major	  steps	  forward	  by	  themselves	  nor	  the	  
knowledge	   in	   term	   of	   policies	   that	   could	   be	   exploited,	   nor	   were	   they	   able	   to	   identify	   the	  
processes	  to	  do	  so.	  What	  proved	  crucial	  in	  getting	  the	  process	  rolling	  was	  their	  expert	  power	  
and	  in-­‐depth	  understanding	  of	  the	  issues	  in	  question.	  The	  professors	  were	  able	  to	  tell	  stories	  
about	  their	  research	  and	  its	  potential	  that	  were	  sufficiently	  convincing	  to	  engage	  other	  actors	  
in	  a	  dialogue.	  The	  scientific	  knowledge	  base	  was	  the	  core,	  but	  the	  future	  prospects	  stemming	  
from	   it	   needed	   to	   be	   reinterpreted	   for	   a	   wider	   audience	   in	   terms	   of	   decision	   and	   policy	  
making;	  actors	  with	  interpretive	  power	  were	  needed	  to	  make	  things	  happen.	  	  
In	  the	  collective	  belief	  formation	  phase,	  the	  lead	  of	  the	  support	  community	  proved	  crucial.	  
The	   support	   community	   emerged	   from	   local	   and	   regional	   development	   agencies,	   as	  well	   as	  
universities,	  and	  consisted	  of	  individuals	  who	  were	  experts	  not	  only	  in	  health	  care	  technology	  
and	   biomaterials	   but	   also	   local/regional	   innovation	   development	   processes	   and	   related	  
policies.	   The	   support	   community	   engaged	   in	   a	   collective	   knowledge	   formation	   process	  
concerning	  what	  might	  be	  gained	  by	  the	  commercialization	  of	  the	  kind	  of	  research	  at	  hand,	  i.e.	  
what	  this	  was	  all	  about,	  how	  to	  proceed	  and	  what	  might	  be	  the	  sources	  of	  funding	  to	  make	  all	  
this	  permanent	   in	  Tampere.	  The	  support	  community	  pushed	   the	  process	   forward	  by	  seeking	  
differences	  and	  similarities	  in	  actors’	  interpretations	  and	  especially	  by	  being	  able	  to	  synthesize	  
different	  ways	  of	  seeing	  the	  common	  issues	  and	  goals	  derived	  from	  them	  in	  collaboration	  with	  
the	   scientific	   and	   clinical	   players.	   Scientific	   hunches	   were	   discussed	   in	   the	   light	   of	   local	  
economic	   developments,	   national	   innovation	   policy	   and	   science	   policy,	   as	   well	   as	   health	  
policies.	  In	  the	  second	  phase,	  the	  driving	  force	  was	  the	  support	  community,	  more	  specifically	  a	  
small	   planning	   group	   assigned	   to	   plan	   for	   the	   next	   phase,	   employing	   adequate	   content	  
knowledge	   complemented	   with	   the	   interpretive	   power	   that	   enabled	   it	   to	   make	   the	   wider	  
societal	  and	  economic	  potential	  visible,	  as	  well	  as	  adequate	  policy	  knowledge	  to	  identify	  and	  
integrate	  several	  local,	  regional,	  national	  and	  European	  policies	  that	  could	  be	  used	  as	  funding	  
sources.	  In	  addition,	  the	  support	  community	  was	  able	  to	  create	  a	  convincing	  interpretation	  of	  
the	  science-­‐based	  business	  potential	  and,	  in	  the	  light	  of	  new	  global	  developments,	  to	  adjust	  to	  
the	  emergent	  collective	  belief	  to	  place	  greater	  emphasis	  on	  academic	  research	  rather	  than	  the	  
business	  venture.	  This	  proved	  important	  in	  moving	  from	  beliefs	  to	  action.	  	  
The	  case	  of	  regenerative	  medicine	  indicates	  that,	  during	  critical	  incidents,	  the	  role	  of	  local	  
and	  regional	  development	  agencies	  as	  brokers	  in	  the	  knowledge	  justification	  process	  becomes	  
pronounced.	   The	   academic	   community	   is	   not	   necessarily	   capable	   of	   navigating	   through	   the	  
various	  policies	   and	  power	   regimes.	   Local	   and	   regional	  development	  agencies	  may	  not	  have	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abundant	  financial	  resources	  or	  much	  understanding	  of	  the	  substantive	  issue	  but	  they	  are	  the	  
ones	   who,	   at	   their	   best,	   can	   exert	   influence	   across	   the	   sectors	   and	   enable	   a	   collective	  
dominant	   belief	   to	   emerge.	   This	   observation,	   for	   its	   part,	   shows	   how	   local/regional	  
development	   agencies	   may	   not	   be	   in	   a	   position	   to	   launch	   new	   processes	   but	   how,	   as	  
intermediaries	  between	  all	   the	   stakeholders,	   they	  may	  carry	   the	  process	   through	   the	  crucial	  
early	  stages.	  What	   they	  have	  here	   is	  knowledge	  of	   relevant	  policies	   to	  be	  utilized	  as	   funding	  
sources	  but,	  even	  more	  importantly,	  they	  are	  in	  a	  position	  to	  mediate	  so	  that	  different	  visions	  
and	  lines	  of	  action	  can	  combine	  as	  one	  that	  provides	  the	  basis	  for	  a	  next	  phase.	  The	  support	  
community	  was	  able	  to	  exercise	  wider	  interpretive	  and	  network	  power	  than	  the	  scientists;	  in	  
the	  support	  community,	  for	  example,	  academic	  thinking	  and	  talk	  was	  translated	  into	  a	  policy	  
language,	  and	  vice	  versa.	  
The	   fourth	  phase,	   the	  actual	   institutionalization	  of	   regenerative	  medicine,	  witnessed	   the	  
first	  breakthrough	  treatments,	  the	  establishment	  of	  an	  institute,	  and	  further	  reorganizations	  of	  
the	  institute,	  first	  within	  University	  of	  Tampere	  and	  later	  between	  the	  two	  universities.	  Here,	  
collective	  belief	  showed	  the	  way	  and	  the	  question	  was	  essentially	  about	  how	  to	  make	  all	  the	  
necessary	  decisions;	  thus,	  the	   institutional	  power	  exercised	  by	  the	   leaders	  of	  the	  universities	  
was	  central	  in	  this	  phase.	  All	  this	  shows	  how	  belief	  formation	  and	  knowledge	  justification	  are	  
at	  the	  core	  of	  institutional	  entrepreneurship	  and	  how	  the	  emergence	  of	  collective	  belief	  –	  and	  
thus	  interpretive	  power	  –	  precedes	  the	  more	  visible	  forms	  of	  institutionalization:	  decisions	  and	  
the	  establishment	  of	  organizations.	  The	  collective	  belief	  formation	  process	  that	  resulted	  in	  the	  
institutionalization	  of	  regenerative	  medicine	  in	  Tampere	  was	  launched	  in	  the	  world	  of	  science	  
but	  it	  was	  not	  able	  to	  progress	  without	  the	  knowledge	  justification	  that	  extended	  beyond	  the	  
boundaries	  of	  the	  laboratory	  to	  the	  world	  of	  local/regional	  development.	  	  
5 Conclusion	  
This	  study	  adds	  to	  the	  literature	  on	  innovation	  systems	  by	  specifically	  focusing	  on	  institutional	  
agency,	   power	   and	   knowledge.	   Conversely,	   it	   adds	   to	   the	   institutional	   entrepreneurship	  
literature	   by	   exploring	   the	   important	   but	   understudied	   link	   between	   institutional	  
entrepreneurship	  and	  innovation	  systems.	  We	  join	  earlier	  studies	  that	  call	  for	  a	  more	  nuanced	  
understanding	  of	  how	  actors	  may	  change	  institutions	  in	  and	  for	  innovation	  systems	  (Hung	  and	  
Whittington,	  2011;	  Ritvala	  and	  Kleymann,	  2012)	  by	  showing	  how	  different	  forms	  of	  knowledge	  
and	  power	  evolve	  with	  a	  process	  while	  simultaneously	  guiding	  it.	  Most	  importantly,	  this	  study	  
links	   purposive	   agency	   into	   the	   literature	   on	   innovation	   systems	   that	   has	   been	   criticized	   for	  
seeing	  policy-­‐makers	  and	  practitioners	  in	  a	  simplistic	  manner	  (Witt,	  2003;	  Uyarra,	  2010).	  
We	  show	  how	   long	  a	  process	   the	   institutionalization	  of	  a	  new	  element	   in	   the	   innovation	  
system	  is.	  Institutionalization	  is	  the	  result	  of	  (a)	  several	  intentions	  being	  aligned	  in	  time	  and	  (b)	  
continuous	   adjustment	   to	   surprises	   caused	   by	   changes	   in	   the	   institutional	   environment.	   As	  
such,	  it	  is	  difficult	  to	  keep	  the	  process	  in	  motion	  so	  that	  it	  does	  not	  break	  down	  during	  critical	  
incidents.	   The	   institutional	   entrepreneurship	   process	   is	   not	   a	   conscious	   and	   pre-­‐designed	  
process	  but	  rather	  a	  phase-­‐by-­‐phase	  process,	  an	  evolving	  search	  for	  next	  steps	  and	  visions.	  It	  
requires	   different	   forms	   of	   knowledge	   and	   power	   in	   different	   phases.	   The	   process	   is	   a	  
contemporary	   version	   of	   ‘muddling	   through	   policies’	   (Lindblom,	   1959),	   in	   which	   vision,	  
strategy	  and	  network	  evolve	  with	  situations.	  Therefore,	  in	  line	  with	  Wrong	  (1997,	  page	  3–10),	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we	  acknowledge	  that	  the	   intentionality	  of	  power	  needs	  to	  be	  scrutinized	  fully	   to	  understand	  
institutionalization,	   how	   institutional	   entrepreneurs	   influence	   each	   other	   and	   the	   wide	  
spectrum	   of	   actors	   necessary	   to	   instigate	   change.	   In	   the	   course	   of	   the	   long	   process	   of	  
institutional	   entrepreneurship,	   belief	   formation	   and	   knowledge	   justification	   are	   essential	   for	  
the	   translation	   of	   different	   forms	   or	   power	   into	   influence	   and	   action.	   Therefore,	   the	   power	  
exercised	  by	  institutional	  entrepreneurs	  is	  relational	  in	  nature.	  It	  draws	  as	  much	  upon	  dialogue	  
and	   interaction	   skills	   as	   on	   expertise	   in	   substantive	   matters,	   legitimate	   power	   and	   formal	  
authority.	  As	   institutional	  power	   follows	  convincing	  belief	   formation	  and	   justified	  knowledge	  
and	   not	   vice	   versa,	   the	   question	   is	   more	   about	   strategies,	   tactics	   and	   the	   capabilities	   of	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i	  Tissue	  bank	  is	  an	  organization	  dealing	  with	  the	  operations	  pertaining	  to	  the	  handling,	  preservation,	  storage,	  and/or	  distribution	  
of	  human-­‐based	  tissues	  or	  cells.	  The	  organization	  may	  also	  be	  responsible	  for	  the	  acquisition	  and	  research	  of	  the	  tissues	  and	  cells	  
(source:	  Regea).	  
ii	  BioneXt	  Tampere	  is	  an	  investment	  and	  development	  programme	  that	  focuses	  on	  biotechnological	  education,	  top-­‐level	  research,	  
product	  development,	  clinical	  application	  and	  possibilities	  in	  international	  commercialization.	  The	  programme	  unites	  the	  strong	  
technological	  expertise	  in	  the	  Tampere	  region	  with	  new	  biological	  and	  medical	  research	  (Bionext,	  2010).	  
iii	  From	  the	  beginning	  of	  2010,	  the	  Centres	  for	  Economic	  Development,	  Transport	  and	  the	  Environment.  
